Suppr超能文献

DNA 流式细胞术作为 I 期肾细胞癌预后的预测指标。

DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma.

作者信息

Grignon D J, el-Naggar A, Green L K, Ayala A G, Ro J Y, Swanson D A, Troncoso P, McLemore D, Giacco G G, Guinee V F

机构信息

Department of Pathology, University of Texas, M. D. Anderson Hospital Cancer Center, Houston, 77030.

出版信息

Cancer. 1989 Mar 15;63(6):1161-5. doi: 10.1002/1097-0142(19890315)63:6<1161::aid-cncr2820630620>3.0.co;2-n.

Abstract

The features most frequently used in predicting the outcome of renal cell carcinoma are stage at presentation and nuclear grade. Recently DNA ploidy pattern, as detected by DNA flow cytometry has also been shown to be predictive. In this study DNA flow cytometry was performed on formalin-fixed paraffin-embedded tissue from 50 patients with Stage I renal cell carcinoma for whom long-term follow-up data were available. Two were eliminated for technical reasons. Of the 48 evaluable tumors, 25 (52%) were diploid, 19 (40%) were nondiploid, and in four, (8%) the ploidy was uncertain. The ploidy pattern was statistically significantly associated with nuclear grade (P less than 0.02), and primary tumor size (P less than 0.05) but did not correlate with cell type, microscopic growth pattern, or the presence or absence of mitotic activity. In the group as a whole, ten patients (21%) died of renal cell carcinoma, seven of 19 (37%) with nondiploid tumor patterns, and two of 25 (8%) with a diploid pattern (P less than 0.03). One of four patients (25%) with tumors of uncertain ploidy also died. However, only two factors, nuclear grade and primary tumor size, were independent predictors of outcome. For Stage I renal cell carcinoma, ploidy can significantly predict patient outcome and correlates with nuclear grade and tumor size, but is not an independent predictive variable.

摘要

预测肾细胞癌预后最常用的特征是就诊时的分期和核分级。最近,通过DNA流式细胞术检测到的DNA倍体模式也已被证明具有预测性。在本研究中,对50例I期肾细胞癌患者的福尔马林固定石蜡包埋组织进行了DNA流式细胞术检测,这些患者均有长期随访数据。因技术原因排除2例。在48例可评估肿瘤中,25例(52%)为二倍体,19例(40%)为非二倍体,4例(8%)倍体情况不确定。倍体模式与核分级(P<0.02)和原发肿瘤大小(P<0.05)在统计学上显著相关,但与细胞类型、显微镜下生长模式或有丝分裂活性的有无无关。在整个研究组中,10例患者(21%)死于肾细胞癌,19例非二倍体肿瘤模式患者中有7例(37%)死亡,25例二倍体模式患者中有2例(8%)死亡(P<0.03)。4例倍体情况不确定的患者中有1例(25%)也死亡。然而,只有两个因素,即核分级和原发肿瘤大小,是预后的独立预测因素。对于I期肾细胞癌,倍体可显著预测患者预后,并与核分级和肿瘤大小相关,但不是一个独立的预测变量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验